KAROLYN WILDER: Open Payments
NPI 1518621994 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 102 payments from 13 companies in 2025. Trend: 2023 $2,025 · 2024 $1,658 · 2025 $2,113
Food & beverage: $2,113
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $478 |
| Neurocrine BioSciences, Inc. | 7 | $269 |
| Axsome Therapeutics, Inc. | 12 | $258 |
| ABBVIE INC. | 25 | $243 |
| Lundbeck LLC | 10 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
| E.R. Squibb & Sons, L.L.C. | 4 | $147 |
| Janssen Pharmaceuticals, Inc | 5 | $142 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
Products named: REXULTI, INGREZZA, Auvelity, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, COBENFY, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
